These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7596122)
21. Myocardial protection with verapamil during ischaemia and reperfusion: dissociation between myocardial salvage and the degree of ATP depletion during ischaemia. Wolfe CL; Donnelly TJ; Sievers R; Parmley WW Cardiovasc Res; 1991 Feb; 25(2):101-9. PubMed ID: 1742760 [TBL] [Abstract][Full Text] [Related]
22. Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A, a nonglucocorticoid 21-aminosteroid. Levitt MA; Sievers RE; Wolfe CL J Cardiovasc Pharmacol; 1994 Jan; 23(1):136-40. PubMed ID: 7511726 [TBL] [Abstract][Full Text] [Related]
23. Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs. Shimizu M; Wang QD; Sjöquist PO; Rydén L J Cardiovasc Pharmacol; 1999 Oct; 34(4):512-7. PubMed ID: 10511125 [TBL] [Abstract][Full Text] [Related]
24. Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure. Su J; Renaud N; Carayon A; Crozatier B; Hittinger L Br J Pharmacol; 1994 Oct; 113(2):395-402. PubMed ID: 7834190 [TBL] [Abstract][Full Text] [Related]
25. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. McMurdo L; Thiemermann C; Vane JR Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665 [TBL] [Abstract][Full Text] [Related]
26. Effects of verapamil and mibefradil on regional blood flow and function in normal and ischemic myocardium. Behrends M; Schulz R; Heusch G Cardiovasc Drugs Ther; 1999 May; 13(3):275-6. PubMed ID: 10439892 [No Abstract] [Full Text] [Related]
27. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil. Cremers B; Flesch M; Südkamp M; Böhm M J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214 [TBL] [Abstract][Full Text] [Related]
28. Calpain inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model. Khalil PN; Neuhof C; Huss R; Pollhammer M; Khalil MN; Neuhof H; Fritz H; Siebeck M Eur J Pharmacol; 2005 Dec; 528(1-3):124-31. PubMed ID: 16324693 [TBL] [Abstract][Full Text] [Related]
29. Effects of Ro 40-5967, a new calcium antagonist, and enalapril on cardiac remodeling in renal hypertensive rats. Véniant M; Clozel JP; Heudes D; Banken L; Ménard J J Cardiovasc Pharmacol; 1993 Apr; 21(4):544-51. PubMed ID: 7681898 [TBL] [Abstract][Full Text] [Related]
30. Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment. Lo HM; Kloner RA; Braunwald E Am J Cardiol; 1985 Oct; 56(10):672-7. PubMed ID: 4050705 [TBL] [Abstract][Full Text] [Related]
31. Verapamil reduces the size of reperfused ischemically injured myocardium in hypertrophied rat hearts as assessed by magnetic resonance imaging. Lauerma K; Saeed M; Wendland MF; Derugin N; Yu KK; Higgins CB Am Heart J; 1996 Jan; 131(1):14-23. PubMed ID: 8554001 [TBL] [Abstract][Full Text] [Related]
32. Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction. Véniant M; Clozel JP; Hess P; Wolfgang R J Cardiovasc Pharmacol; 1991 Feb; 17(2):277-84. PubMed ID: 1709233 [TBL] [Abstract][Full Text] [Related]
33. Effects of calcium antagonists on infarcting myocardium. Kloner RA; Braunwald E Am J Cardiol; 1987 Jan; 59(3):84B-94B. PubMed ID: 3544791 [TBL] [Abstract][Full Text] [Related]
34. Intrathecal morphine reduces infarct size in a rat model of ischemia-reperfusion injury. Groban L; Vernon JC; Butterworth J Anesth Analg; 2004 Apr; 98(4):903-909. PubMed ID: 15041570 [TBL] [Abstract][Full Text] [Related]
35. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts. Orito K; Satoh K; Taira N J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172 [TBL] [Abstract][Full Text] [Related]
36. Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on ischemia and reperfusion-induced myocardial infarction in rats and dogs. Oh KS; Seo HW; Yi KY; Lee S; Yoo SE; Lee BH Fundam Clin Pharmacol; 2007 Jun; 21(3):255-63. PubMed ID: 17521294 [TBL] [Abstract][Full Text] [Related]